Status:
COMPLETED
Surface Acoustic Wave Ultrasound in Trigeminal Neuralgia Pain
Lead Sponsor:
Sheba Medical Center
Conditions:
Trigeminal Neuralgia
Tic Douloureux
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The "Suicide Disease", Trigeminal Neuralgia (TN) is arguably caused by one of the most discrete and eloquently reversible central nervous system lesions known to the field of neurology. Recently Dr A...
Detailed Description
1. Introduction: Trigeminal neuralgia (TN) is one of the most severe and progressive forms of chronic neuropathic pain. The latest scientific work has shown that the most likely cause of TN is...
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18 years or above.
- Diagnosed with trigeminal neuralgia refractory to medical treatment (modified BNI V).
Exclusion
- Male or female, under the age of 18.
- Active illicit drug use
- Pregnancy.
- Psychiatric illness which may prevent the patient from participation in the study.
- Anesthesia dolorosa with pain greater than or equal to 3/10
- Dental implants.
- Other known pathology of the trigeminal nerve including iatrogenic anesthesia dolorosa.
- Cancer and bone metastases.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT01447108
Start Date
November 1 2011
End Date
November 1 2012
Last Update
December 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center
Tel Litwinsky, Israel, 52621